First-in-Human: Reach milestones sooner with a technology-driven approach to early-stage biologic development Free White Paper

Request Your Free White Paper Now:

"First-in-Human: Reach milestones sooner with a technology-driven approach to early-stage biologic development"

View detailed description

Get Started

Complete the form below:

Work Email Address

First Name

Last Name

Company Name

Job Title

Job Area

Please Specify
for Other:

Work Phone Number

Company Size

Company Industry

Please Specify
for Other:

Company Street Address

Company Suite/Office

Company Postal/Zip Code

Company City

Company State

Company Country

Summary

To learn more about Patheon’s innovations in early phase biologics development, visit patheon.com/biologics

*Terms and Conditions: Titer levels provided are estimates based on third party results and may vary depending on molecule type or other factors. Timeline from DNA to drug product and start of clinical trials for all path to IND for biologics options may vary depending on molecule type or other factors and are estimates to be finalized after third party cell line development dates are available and confirmed. 9-month timeline will incur additional risk.

I acknowledge and agree to the use of my contact information to receive messages about offerings by Questex, its brands, affiliates and/or third-party partners, consistent with Questex Privacy Policy

Valid email address is required to fulfill your request.

To learn more about how your data is processed, stored, and kept secure please read our Privacy Policy.

Request Your Free White Paper Now: